What Researchers Did
Researchers evaluated the efficacy of efferent therapy, including plasmapheresis, ultraviolet irradiation of blood, and hyperbaric oxygen therapy, in 197 patients with great vessel injuries and acute limb ischemia.
What They Found
Patients receiving efferent therapy had significantly lower rates of limb amputation (1.96% vs. 17.8%) and necrectomy (2.8% vs. 11.1%) compared to the control group. Mortality was also substantially lower in the main group (0.94% vs. 7.8%), and hospital stay was reduced by two-fold.
What This Means for Canadian Patients
For Canadian patients experiencing severe great vessel injuries or acute limb ischemia, incorporating efferent therapies like plasmapheresis and hyperbaric oxygen could potentially reduce the need for amputations and improve survival rates. This approach might also lead to shorter hospital stays, facilitating quicker recovery and reducing healthcare burden.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A limitation of this study is that it was conducted at a single center, which may affect the generalizability of the findings.